DK1262181T3 - Brug af isothiazolderivater som ureasehæmmere for behandling af gastrointestinale sygdomme forårsaget af Heliobacter pylori - Google Patents
Brug af isothiazolderivater som ureasehæmmere for behandling af gastrointestinale sygdomme forårsaget af Heliobacter pyloriInfo
- Publication number
- DK1262181T3 DK1262181T3 DK01908245T DK01908245T DK1262181T3 DK 1262181 T3 DK1262181 T3 DK 1262181T3 DK 01908245 T DK01908245 T DK 01908245T DK 01908245 T DK01908245 T DK 01908245T DK 1262181 T3 DK1262181 T3 DK 1262181T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- gastrointestinal disorders
- disorders caused
- urease inhibitors
- heliobacter pylori
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000062012A JP2001247462A (ja) | 2000-03-07 | 2000-03-07 | ウレアーゼ阻害剤 |
| PCT/JP2001/001618 WO2001066112A1 (fr) | 2000-03-07 | 2001-03-02 | Inhibiteurs d'urease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1262181T3 true DK1262181T3 (da) | 2007-09-10 |
Family
ID=18582077
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01908245T DK1262181T3 (da) | 2000-03-07 | 2001-03-02 | Brug af isothiazolderivater som ureasehæmmere for behandling af gastrointestinale sygdomme forårsaget af Heliobacter pylori |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20030060482A1 (de) |
| EP (1) | EP1262181B1 (de) |
| JP (1) | JP2001247462A (de) |
| KR (1) | KR20030016235A (de) |
| CN (1) | CN1171589C (de) |
| AT (1) | ATE362366T1 (de) |
| AU (2) | AU2001236052B2 (de) |
| CA (1) | CA2400527A1 (de) |
| DE (1) | DE60128448T2 (de) |
| DK (1) | DK1262181T3 (de) |
| ES (1) | ES2284619T3 (de) |
| PT (1) | PT1262181E (de) |
| WO (1) | WO2001066112A1 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ2006427A3 (cs) | 2003-12-29 | 2006-11-15 | Sepracor Inc. | Pyrrolové a pyrazolové inhibitory DAAO |
| CN1922157B (zh) | 2003-12-29 | 2011-01-12 | 塞普拉科公司 | 苯并[d]异噁唑-3-醇DAAO抑制剂 |
| JP2009500425A (ja) | 2005-07-06 | 2009-01-08 | セプラコア インコーポレーテッド | エスゾピクロン及びトランス４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロ−ｎ−メチル−１−ナフタレンアミン又はトランス４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロ−１−ナフタレンアミンの組み合わせ、並びに閉経期並びに気分、不安、及び認知障害の治療方法 |
| ES2566479T3 (es) | 2006-01-06 | 2016-04-13 | Sunovion Pharmaceuticals Inc. | Inhibidores de reabsorción de monoamina con base en tetralona |
| US20070203111A1 (en) | 2006-01-06 | 2007-08-30 | Sepracor Inc. | Cycloalkylamines as monoamine reuptake inhibitors |
| EP2816024B8 (de) | 2006-03-31 | 2018-04-04 | Sunovion Pharmaceuticals Inc. | Chirale Amine |
| EP2061472A4 (de) * | 2006-05-22 | 2010-12-22 | Thioredoxin Systems Ab | Bakterielle thioredoxin-reductase-hemmer und anwendungsverfahren dafür |
| US7884124B2 (en) | 2006-06-30 | 2011-02-08 | Sepracor Inc. | Fluoro-substituted inhibitors of D-amino acid oxidase |
| US7902252B2 (en) | 2007-01-18 | 2011-03-08 | Sepracor, Inc. | Inhibitors of D-amino acid oxidase |
| JP5420534B2 (ja) | 2007-05-31 | 2014-02-19 | サノビオン ファーマシューティカルズ インク | モノアミン再取り込み阻害薬としてのフェニル置換シクロアルキルアミン |
| CN101560189B (zh) * | 2009-05-20 | 2011-02-16 | 南京大学 | 甲硝唑和取代水杨酸的复合物及其制法与用途 |
| EP2925734B1 (de) * | 2012-11-28 | 2016-10-05 | Rohm and Haas Company | Verfahren zur herstellung von 2-alkyl-1,2-benzisothiazolin-3-onen |
| CN103012309A (zh) * | 2013-01-23 | 2013-04-03 | 寿光新泰精细化工有限公司 | 一种2-甲基-1,2-苯并异噻唑啉-3-酮的合成方法 |
| US10058542B1 (en) | 2014-09-12 | 2018-08-28 | Thioredoxin Systems Ab | Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith |
| WO2016085655A1 (en) * | 2014-11-26 | 2016-06-02 | Rohm And Haas Company | Method for preparation of 2-methyl-1,2-benzisothiazolin-3-one |
| GB2544109A (en) * | 2015-11-06 | 2017-05-10 | Visa Europe Ltd | Transaction authorisation |
| CN105753805A (zh) * | 2016-03-31 | 2016-07-13 | 寿光新泰精细化工有限公司 | 一种1,2-苯并异噻唑-3-酮的提纯方法 |
| CN105801516B (zh) * | 2016-04-28 | 2018-05-04 | 大丰跃龙化学有限公司 | 一种1,2-苯并异噻唑啉-3-酮提纯工艺 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62273903A (ja) * | 1986-05-22 | 1987-11-28 | Kurita Water Ind Ltd | 防腐剤 |
| JPH0477476A (ja) * | 1990-07-19 | 1992-03-11 | Sankyo Co Ltd | 抗潰瘍剤 |
| JP2839827B2 (ja) * | 1993-10-05 | 1998-12-16 | 大塚製薬株式会社 | ウレアーゼ阻害剤 |
| JPH08314097A (ja) * | 1995-05-15 | 1996-11-29 | Fuji Photo Film Co Ltd | ハロゲン化銀写真感光材料の収納保存方法 |
| JPH10109912A (ja) * | 1996-10-04 | 1998-04-28 | Akio Suganuma | 抗菌組成物 |
| JP3940201B2 (ja) * | 1997-05-20 | 2007-07-04 | 大塚製薬株式会社 | ３，３’−ジチオジベンゾヒドロキサム酸 |
-
2000
- 2000-03-07 JP JP2000062012A patent/JP2001247462A/ja active Pending
-
2001
- 2001-03-02 CA CA002400527A patent/CA2400527A1/en not_active Abandoned
- 2001-03-02 AT AT01908245T patent/ATE362366T1/de not_active IP Right Cessation
- 2001-03-02 WO PCT/JP2001/001618 patent/WO2001066112A1/ja active IP Right Grant
- 2001-03-02 EP EP01908245A patent/EP1262181B1/de not_active Expired - Lifetime
- 2001-03-02 KR KR1020027011639A patent/KR20030016235A/ko not_active Application Discontinuation
- 2001-03-02 DE DE60128448T patent/DE60128448T2/de not_active Expired - Fee Related
- 2001-03-02 ES ES01908245T patent/ES2284619T3/es not_active Expired - Lifetime
- 2001-03-02 CN CNB018062083A patent/CN1171589C/zh not_active Expired - Fee Related
- 2001-03-02 DK DK01908245T patent/DK1262181T3/da active
- 2001-03-02 PT PT01908245T patent/PT1262181E/pt unknown
- 2001-03-02 AU AU2001236052A patent/AU2001236052B2/en not_active Ceased
- 2001-03-02 AU AU3605201A patent/AU3605201A/xx active Pending
- 2001-03-02 US US10/220,803 patent/US20030060482A1/en not_active Abandoned
-
2003
- 2003-09-25 US US10/669,700 patent/US20040058952A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2400527A1 (en) | 2001-09-13 |
| US20030060482A1 (en) | 2003-03-27 |
| US20040058952A1 (en) | 2004-03-25 |
| DE60128448D1 (de) | 2007-06-28 |
| JP2001247462A (ja) | 2001-09-11 |
| CN1171589C (zh) | 2004-10-20 |
| CN1422155A (zh) | 2003-06-04 |
| KR20030016235A (ko) | 2003-02-26 |
| DE60128448T2 (de) | 2008-01-17 |
| AU3605201A (en) | 2001-09-17 |
| PT1262181E (pt) | 2007-06-27 |
| ATE362366T1 (de) | 2007-06-15 |
| WO2001066112A1 (fr) | 2001-09-13 |
| EP1262181A1 (de) | 2002-12-04 |
| EP1262181B1 (de) | 2007-05-16 |
| ES2284619T3 (es) | 2007-11-16 |
| EP1262181A4 (de) | 2004-10-13 |
| AU2001236052B2 (en) | 2005-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1262181T3 (da) | Brug af isothiazolderivater som ureasehæmmere for behandling af gastrointestinale sygdomme forårsaget af Heliobacter pylori | |
| DK1651232T3 (da) | Forbindelser mod inflammation og immunrelaterede anvendelser | |
| CY1111951T1 (el) | Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου | |
| DK1065204T3 (da) | Bicykliske carbonyl-indolforbindelser som anti-inflammatoriske/analgesiske midler og som COX-2-inhibitorer | |
| MY141661A (en) | 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
| DK1217001T3 (da) | Quinuclidinforbindelser og lægemidler indeholdende dem som den aktive bestanddel | |
| NO20003018L (no) | Triazinangiogenese-inhibitorer | |
| BR0113389A (pt) | Compostos que inibem a atividade do fator xa | |
| MX2009006638A (es) | Agente para erradicar helicobacter pylori que tiene actividad inhibidora sobre la secrecion de acido gastrico. | |
| DK1256581T3 (da) | Forebyggende eller terapeutiske midler til gastrisk eller ösofageal regurgitation | |
| IL150965A0 (en) | Therapeutic or preventive agent for digestive system diseases containing a diaminotrifluoromethylpyridine derivative | |
| NO20030061L (no) | Tyrosinderivater som fosfataseinhibitorer | |
| DK0913151T3 (da) | Anti-helicobacter Pylori-præparater indeholdende 1-methylcarbapenemderivater som den aktive bestanddel | |
| ATE240957T1 (de) | Optisch aktive pyrrolopyridazin-derivate | |
| PT1049672E (pt) | Derivados de azetidinocarboxamida para o tratamento de disturbios do snc | |
| HK1122290A1 (en) | Novel pyridine derivative having anti-helicobacter pylori activity | |
| MXPA06000651A (es) | Uso de derivados de indazol para el tratamiento de dolor neuropatico. | |
| PT1049670E (pt) | Derivados de azetidinocarboxamida para o tratamento de perturbacoes do snc | |
| TH83161A (th) | อนุพันธ์ไตรอะโซลิดีนซึ่งใช้กำจัดเห็บ | |
| TH83161B (th) | อนุพันธ์ไตรอะโซลิดีนซึ่งใช้กำจัดเห็บ | |
| EA200800125A1 (ru) | Фармацевтическая композиция, включающая 1-(3-хлорфенил)-3-алкилпиперазин, для лечения расстройств аппетита |